There is NO SHOT IN HELL this current application is for tumor agnostic. That requires at least a pivotal basket trial or individual pivotal trials. Tumor agnostic is never going to happen under this team. Sorry that is many many years away. Let's be real here. This isn't about multiple jurisdictions or mutliple indications. These guys are just slow AF.
Market Data 
Markets 
AI
